共 50 条
- [1] Novel benzoxazole inhibitors of mPGES-1BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2013, 23 (03) : 907 - 911Kablaoui, NatashaPatel, SnahelShao, JayDemian, DouglasHoffmaster, KeithBerlioz, FrancioiseVazquez, Michael L.Moore, William M.Nugent, Richard A.
- [2] A review on mPGES-1 inhibitors: From preclinical studies to clinical applicationsPROSTAGLANDINS & OTHER LIPID MEDIATORS, 2020, 147Bergqvist, FilipMorgenstern, RalfJakobsson, Per-Johan
- [3] Trisubstituted ureas as potent and selective mPGES-1 inhibitorsBIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (05) : 1488 - 1492Chiasson, Jean-FrancoisBoulet, LouiseBrideau, ChristineChau, AnhClaveau, DavidCote, BernardEthier, DianeGiroux, AndreGuay, JocelyneGuiral, SebastienMancini, JosephMasse, FredericMethot, NathalieRiendeau, DenisRoy, PatrickRubin, JoelXu, DaigenYu, HongpingDucharme, YvesFriesen, Richard W.
- [4] Identification and development of mPGES-1 inhibitors: where we are at?FUTURE MEDICINAL CHEMISTRY, 2011, 3 (15) : 1909 - 1934Chang, Hui-HuaMeuillet, Emmanuelle J.
- [5] Computational design, synthesis and characterization of novel mPGES-1 inhibitorsABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253Zhou, ZiyuanDing, KaiZhou, ShuoYuan, YaxiaZheng, FangZhan, Chang-Guo
- [6] Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptorsMOLECULAR DIVERSITY, 2017, 21 (03) : 661 - 675Xia, ZhonghuaYan, Aixia
- [7] Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptorsMolecular Diversity, 2017, 21 : 661 - 675Zhonghua XiaAixia Yan
- [8] mPGES-1 deletion increases prostacyclin and evades the elevated systemic ADMA associatedwith COX-2 inhibitors: relevance to cardiovascular safety of mPGES-1 inhibitorsSCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 24 - 25Raouf, J.Kirkby, N.Ahmetaj-Shala, B.Liu, B.MRes, S. M.Korotkova, M.Zeldin, D.Zhou, Y.Jakobsson, P-JMitchell, J.
- [9] mPGES-1 DELETION INCREASES PROSTACYCLIN AND EVADES THE ELEVATED SYSTEMIC ADMA ASSOCIATED WITH COX-2 INHIBITORS: RELEVANCE TO CARDIOVASCULAR SAFETY OF mPGES-1 INHIBITORSANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A11 - +Raouf, J.Kirkby, N. S.Ahmetaj-Shala, B.Liu, B.Mazi, S. I.Korotkova, M.Zhou, Y.Mitchell, J. A.Jakobsson, P. J.
- [10] Arylpyrrolizines as Inhibitors of Microsomal Prostaglandin E2 Synthase-1 (mPGES-1) or as Dual Inhibitors of mPGES-1 and 5-Lipoxygenase (5-LOX)JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (15) : 4968 - 4972Liedtke, Andy J.Keck, Peter R. W. E. F.Lehmann, FrankKoeberle, AndreasWerz, OliverLaufer, Stefan A.